(December 14, 2015, 2:11 PM EST) -- INDIANAPOLIS — Six months after denying a stay in a patent dispute over a platelet inhibiting drug, an Indiana federal magistrate judge on Dec. 11 reversed course, agreeing to stay the litigation pending resolution of inter partes review (IPR) (Eli Lilly and Company, et al. v. Accord Healthcare Inc. USA, et al., No. 14-389, S.D. Ind.; 2015 U.S. Dist. LEXIS 166106).

(Order available. Document #16-160105-003R.)

According to U.S. Magistrate Judge Tim A. Baker of the Southern District of Indiana, “this time around,” the arguments advanced are...